Pentoxifylline as an adjunct therapy in children with cerebral malaria
Background. Pentoxifylline (PTX) affects many processes that may contribute to the pathogenesis of severe malaria and it has been shown to reduce the duration of coma in children with cerebral malaria. This pilot study was performed to assess pharmacokinetics, safety and efficacy of PTX in African c...
Prif Awduron: | Lell, B, Köhler, C, Wamola, B, Olola, C, Kivaya, E, Kokwaro, G, Wypij, D, Mithwani, S, Taylor, T, Kremsner, P, Newton, C |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
BioMed Central
2010
|
Eitemau Tebyg
-
Pentoxifylline as an adjunct therapy in children with cerebral malaria.
gan: Lell, B, et al.
Cyhoeddwyd: (2010) -
Pentoxifylline as adjunct therapy in childen with cerebral malaria [MIM-BL-72864]
gan: Lell, B, et al.
Cyhoeddwyd: (2005) -
The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children.
gan: Ogutu, B, et al.
Cyhoeddwyd: (2005) -
Prognostic value of circulating pigmented cells in African children with malaria.
gan: Kremsner, P, et al.
Cyhoeddwyd: (2009) -
Cerebral malaria: optimising management.
gan: Mturi, N, et al.
Cyhoeddwyd: (2003)